What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?

Authors

  • Gunnar Steineck Division of Clinical Cancer Epidemiology, Institute of Clinical Sciences, The Sahlgrenska Academy at University of Gothenburg, Sahlgrenska University Hospital, Gothenburg
  • Bengt Glimelius Department of Radiology, Oncology and Radiation Science, Uppsala University, Uppsala, Sweden

DOI:

https://doi.org/10.3109/0284186X.2013.821206

Abstract

No abstract available

Downloads

Download data is not yet available.

Downloads

Published

2013-11-01

How to Cite

Steineck, G., & Glimelius, B. (2013). What is the appropriate use of palliative docetaxel in castration-resistant prostate cancer?. Acta Oncologica, 52(8), 1589–1592. https://doi.org/10.3109/0284186X.2013.821206

Issue

Vol. 52 No. 8 (2013): Acta Oncologica

Section

Articles